Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Dapoxetine
2. Ly 210448
3. Ly-210448
4. N,n-dimethyl-alpha-(2-(1-naphthalenyloxy)ethyl)benzenemethanamine
5. Priligy
1. 129938-20-1
2. Dapoxetine Hcl
3. Priligy
4. Dapoxetine, Hcl
5. (s)-n,n-dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine Hydrochloride
6. Ly-210448 Hydrochloride
7. Ly210448 Hcl
8. Dapoxetine (hydrochloride)
9. Dapoxetine Hydrochloride [usan]
10. U4oht63mri
11. (+)-dapoxetine Hydrochloride
12. Dapoxetine (as Hydrochloride)
13. Dapoxetine Hydrochloride (priligy)
14. 129938-20-1 (hcl)
15. Ly 210448 Hydrochloride
16. Dapoxetine Hydrochloride (usan)
17. (1s)-n,n-dimethyl-3-naphthalen-1-yloxy-1-phenylpropan-1-amine;hydrochloride
18. Unii-u4oht63mri
19. Dapoxetine .hcl
20. C21h23no.hcl
21. Schembl119037
22. Chembl2106574
23. Hy-b0304a
24. Dtxsid20926531
25. Ex-a4046
26. Dapoxetine Hydrochloride [mi]
27. Mfcd08272809
28. S1869
29. (+)-(s)-n,n-dimethyl-alpha-(2-(1-naphthyloxy)ethyl)benzylamine Hydrochloride
30. Akos015889488
31. Ccg-267940
32. Ks-5240
33. Dapoxetine Hydrochloride [mart.]
34. Dapoxetine Hydrochloride [who-dd]
35. Ac-22602
36. Bd164348
37. Dapoxetine Hydrochloride, >=98% (hplc)
38. D4761
39. Sw219444-1
40. D03649
41. F15016
42. 938d201
43. J-005725
44. Q27290682
45. (s)-n,n-dimethyl-3-(1-naphthyloxy)-1-phenyl-1-propylamine Hydrochloride
46. (s)-n,n-dimethyl-3-(1-naphthyloxy)-1-phenylpropylamine Hydrochloride
47. (s)-n,n-dimethyl-alpha-[2-(1-naphthyloxy)ethyl]benzylamine Hydrochloride
48. (+)-(s)-n,n-dimethyl-.alpha.-(2-(1-naphthyloxy)ethyl)benzylamine Hydrochloride
49. (1s)-n,n-dimethyl-3-naphthalen-1-yloxy-1-phenylpropan-1-amine;hydrochloride.
50. (s)-n,n-dimethyl-?-[2-(1-naphthalenyloxy)ethyl]benzenemethanamine Hydrochloride
51. (s)-n,n-dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-aminehydrochloride
52. (s)-n,n-dimethyl-alpha-[2-(1-naphthaleny Loxy)ethyl]benzenemethanamine Hydrochloride
53. Benzenemethanamine, N,n-dimethyl-a-[2-(1-naphthalenyloxy)ethyl]-,hydrochloride, (s)-
54. Benzenemethanamine, N,n-dimethyl-alpha-(2-(1-naphthalenyloxy)ethyl)-, Hydrochloride, (s)-
55. N,n-dimethyl-3-[(naphthalen-1-yl)oxy]-1-phenylpropan-1-amine--hydrogen Chloride (1/1)
56. Benzenemethanamine, N,n-dimethyl-.alpha.-(2-(1-naphthalenyloxy)ethyl)-, Hydrochloride, (s)-
57. Benzenemethanamine, N,n-dimethyl-alpha-(2-(1-naphthalenyloxy)ethyl)-, Hydrochloride, (alphas)-
| Molecular Weight | 341.9 g/mol |
|---|---|
| Molecular Formula | C21H24ClNO |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 6 |
| Exact Mass | 341.1546421 g/mol |
| Monoisotopic Mass | 341.1546421 g/mol |
| Topological Polar Surface Area | 12.5 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 337 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Dapoxetine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dapoxetine Hydrochloride, including repackagers and relabelers. The FDA regulates Dapoxetine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dapoxetine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dapoxetine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dapoxetine Hydrochloride supplier is an individual or a company that provides Dapoxetine Hydrochloride active pharmaceutical ingredient (API) or Dapoxetine Hydrochloride finished formulations upon request. The Dapoxetine Hydrochloride suppliers may include Dapoxetine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Dapoxetine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dapoxetine Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Dapoxetine Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Dapoxetine Hydrochloride DMFs exist exist since differing nations have different regulations, such as Dapoxetine Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dapoxetine Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Dapoxetine Hydrochloride USDMF includes data on Dapoxetine Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dapoxetine Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dapoxetine Hydrochloride suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Dapoxetine Hydrochloride Drug Master File in Korea (Dapoxetine Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Dapoxetine Hydrochloride. The MFDS reviews the Dapoxetine Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Dapoxetine Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Dapoxetine Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Dapoxetine Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Dapoxetine Hydrochloride suppliers with KDMF on PharmaCompass.
A Dapoxetine Hydrochloride written confirmation (Dapoxetine Hydrochloride WC) is an official document issued by a regulatory agency to a Dapoxetine Hydrochloride manufacturer, verifying that the manufacturing facility of a Dapoxetine Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Dapoxetine Hydrochloride APIs or Dapoxetine Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Dapoxetine Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Dapoxetine Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dapoxetine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dapoxetine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dapoxetine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dapoxetine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dapoxetine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dapoxetine Hydrochloride suppliers with NDC on PharmaCompass.
Dapoxetine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dapoxetine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dapoxetine Hydrochloride GMP manufacturer or Dapoxetine Hydrochloride GMP API supplier for your needs.
A Dapoxetine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Dapoxetine Hydrochloride's compliance with Dapoxetine Hydrochloride specifications and serves as a tool for batch-level quality control.
Dapoxetine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Dapoxetine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dapoxetine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Dapoxetine Hydrochloride EP), Dapoxetine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dapoxetine Hydrochloride USP).
LOOKING FOR A SUPPLIER?
